Tai‐Nin Chau, Kam‐Cheong Lee, Hung Yao, Tak‐Yin Tsang, Tat‐Chong Chow, Yiu‐Cheong Yeung, Kin‐Wing Choi, Yuk‐Keung Tso, Terence Lau, Sik‐To Lai, Ching‐Lung Lai – 30 January 2004 – Liver impairment is commonly reported in up to 60% of patients who suffer from severe acute respiratory syndrome (SARS). Here we report the clinical course and liver pathology in three SARS patients with liver impairment. Three patients who fulfilled the World Health Organization case definition of probable SARS and developed marked elevation of alanine aminotransferase were included.

Fin Stolze Larsen – 30 January 2004

Sarwa Darwish Murad, Dominique‐Charles Valla, Piet C. de Groen, Guy Zeitoun, Judith A.M. Hopmans, Elizabeth B. Haagsma, Bart van Hoek, Bettina E. Hansen, Frits R. Rosendaal, Harry L.A. Janssen – 30 January 2004 – Budd‐Chiari syndrome (BCS) is a rare disorder that is characterized by hepatic venous outflow obstruction. The aim of this study was to assess determinants of survival and to evaluate the effect of portosystemic shunting. In this international multicenter study, 237 patients with BCS, diagnosed between 1984 and 2001, were investigated.

Shan Zeng, Nikki Feirt, Michael Goldstein, James Guarrera, Nikalesh Ippagunta, Udeme Ekong, Hao Dun, Yan Lu, Wu Qu, Ann Marie Schmidt, Jean C. Emond – 30 January 2004 – Hepatic ischemia/reperfusion (I/R) injury associated with liver transplantation and hepatic resection is characterized by hepatocellular damage and a deleterious inflammatory response. In this study, we examined whether receptor for advanced glycation end product (RAGE) activation is linked to mechanisms accentuating inflammation on I/R in a murine model of total hepatic ischemia.

Jose M. Estrela, Angel L. Ortega, Julian Carretero – 30 January 2004

Thomas D. Boyer – 30 January 2004

Elisabetta Cerutti, Chiara Stratta, Renato Romagnoli, Maria Maddalena Schellino, Stefano Skurzak, Mario Rizzetto, Giacomo Tamponi, Mauro Salizzoni – 30 January 2004 – Living donor liver transplantation (LDLT) is becoming a widespread procedure. However, the risk of surgical and medical complications in healthy donors is still a major concern. Hypercoagulability contributes to thromboembolic complications after surgery, but alterations of hemostasis after liver resection are difficult to predict.

Jordi Blanch, Barbara Sureda, Montse Flaviá, Victoria Marcos, Joan de Pablo, Elisa De Lazzari, Antoni Rimola, Victor Vargas, Victor Navarro, Carlos Margarit, Josep Visa – 30 January 2004 – Although the survival rate of patients undergoing orthotopic liver transplantation (OLT) is highly satisfactory, one of the most important objectives for liver transplantation teams at the present time is to achieve the best possible quality of life and psychosocial functioning for these patients after transplantation.

Jose C. FernÁndez‐Checa, Carmen Garcia‐Ruiz – 30 January 2004

Shiqi Yang, Ayman Koteish, Huizhi Lin, Jiawen Huang, Tania Roskams, Valina Dawson, Anna Mae Diehl – 30 January 2004 – Hepatic steatosis may have a generally benign prognosis, either because most hepatocytes are not significantly injured or mechanisms to replace damaged hepatocytes are induced.